Skip to main content
. 2021 Feb 19;268(9):3116–3124. doi: 10.1007/s00415-021-10444-6

Fig. 4.

Fig. 4

Change in serum total alpha-synuclein (αSyn) levels before and after the onset of neurological manifestations